logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Figure PDU-2. Estimates of the prevalence of injecting drug use (rate per 1000 population aged 15 to 64), studies from 2001 to 2005


Methods of estimation are abbreviated: CR=Capture-recapture; TM =Treatment multiplier; PM = Police multiplier; MI = Multivariate indicator; TP= Truncated Poisson; CM = Combined methods; MM= Mortality multiplier; MME = Multiplier Method.

The symbol indicates a point estimate, a bar indicates an uncertainty interval, which can be either a 95%-confidence interval or an interval based on sensitivity analysis (see Table PDU-3).

Target groups may vary slightly owing to different methods and data sources; therefore comparisons should be made with caution.

Mortality and HIV multipliers are assumed to give estimates of (mainly current) injecting drug use, which is only part of problem drug use.

* - Estonia: Original age range of study was 15-44, rates have been adjusted to 15-64.


SB2006: Figure PDU-02 part (i)

For more details see Tables PDU-1 to PDU-3 in the 2007 Statistical Bulletin.

See also EMCDDA project (2003): National prevalence estimates of problem drug use in the European Union, 1995–2000, CT.00.RTX.23, EMCDDA, Lisbon, coordinated by the Institut für Therapieforschung, Munich (http://www.emcdda.eu.int/?nnodeid=1372).

See also 'General notes for interpreting data' on the Explanatory notes and help page.


National Focal Points.

Page last updated: Friday, 23 November 2007